Facebook Twitter LinkedIn Google Plus RSS

Agile Therapeutics announces pricing of IPO

By ,

Princeton-based Agile Therapeutics Inc., a women’s health specialty pharmaceutical company, announced Thursday that it has priced its initial public offering.

According to the announcement, 9.16 million share of its common stock will be priced to the public at $6.00 per share.  Agile has granted underwriters a 30-day option to purchase up to an additional 1.375 million additional shares to cover any over-allotments.

The shares are expected to begin trading on the NASDAQ on May 23, 2014 under the symbol “AGRX.” The offering should close on May 29, 2014, the announcement said.

Bookrunning managers for the offering are RBC Capital Markets LLC and William Blair & Co. LLC.   Also, Cantor Fitzgerald & Co. and Janney Montgomery Scott LLC are co-managers.


Hess sells retail gas business for $2.8B

Jersey City files $400 million lawsuit against Port Authority over tax agreements

Most-read May 22: Longtime N.J. company may be headed out of state

You May Have Missed...

Emily Bader

Emily Bader

Emily Bader is the Web Editor and Social Media Coordinator at NJBIZ. She is a Brielle, N.J. native and a Rutgers University alum. You can contact her at emilyb@njbiz.com.

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy